About the Master

Jeffrey Cummings is a world-renowned neurologist, winner of the Bengt Winblad Lifetime Achievement Award (2018) from the US Alzheimer’s Association, and Professor at the Cleveland Clinic Lou Ruvo Center for Brain Health.

About the e-Class

Due to Alzheimer's disease’s long course, complex pathological mechanism and many high-risk factors, the research and treatment of AD has always been a global conundrum. According to statistics, from 1998 to 2017, 146 AD drugs around the world failed during clinical research and development – 40% ended prematurely in the early clinical stage, 39% declared failure in the mid clinical stage, and 18% stalled in the late clinical stage.